Zic family member 5 promotes survival in human pancreatic cancer and cholangiocarcinoma cells

Pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA) are malignant tumors with poor prognosis because of the limited effectiveness of traditional chemotherapy and few effective molecular therapeutic agents. Here, we determined the essential roles of Zic family member 5 (ZIC5) in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Satow, Reiko, Aiga, Yuna, Watanabe, Takeru, Ishizuka, Nako, Yoneda, Atsuko, Fukami, Kiyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166430/
https://www.ncbi.nlm.nih.gov/pubmed/35669984
http://dx.doi.org/10.1016/j.bbrep.2022.101289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166430/
https://www.ncbi.nlm.nih.gov/pubmed/35669984
http://dx.doi.org/10.1016/j.bbrep.2022.101289

Ejemplares similares